{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:59:51Z","timestamp":1785272391835,"version":"3.55.0"},"reference-count":16,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,1,6]]},"published-print":{"date-parts":[[2026,4]]},"DOI":"10.2967\/jnumed.125.271511","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T17:10:12Z","timestamp":1769706612000},"page":"590-593","source":"Crossref","is-referenced-by-count":1,"title":["Mass Dose Effects in FAP-Directed Imaging: Influence of Administered Dose of [\n                    <sup>68<\/sup>\n                    Ga]Ga-LNTH-1363S on Image Quality"],"prefix":"10.2967","volume":"67","author":[{"given":"Johanna S.","family":"Enke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Baessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitasha","family":"Chand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Glantschnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Sjoestrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Trepel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Orcutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Dreher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Patt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Dierks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Lapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"2026040105551055000_67.4.590.1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S1470-2045(25)00299-2","article-title":"[68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial","volume":"26","author":"Pabst","year":"2025","journal-title":"Lancet Oncol."},{"key":"2026040105551055000_67.4.590.2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.9.3110"},{"key":"2026040105551055000_67.4.590.3","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.269793"},{"key":"2026040105551055000_67.4.590.4","first-page":"241693","article-title":"First-in-human study of a high affinity FAP imaging agent [Cu-64]LNTH-1363S [abstract]","volume":"65","author":"Hesterman","year":"2024","journal-title":"J Nucl Med."},{"key":"2026040105551055000_67.4.590.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3452"},{"key":"2026040105551055000_67.4.590.6","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s11307-021-01593-1","article-title":"A trifunctional theranostic ligand targeting fibroblast activation protein-a (FAPa)","volume":"23","author":"Kelly","year":"2021","journal-title":"Mol Imaging Biol."},{"key":"2026040105551055000_67.4.590.7","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1007\/s00259-025-07071-y","article-title":"The molar dose of FAPI administered impacts on the FAP-targeted PET imaging and therapy in mouse syngeneic tumor models","volume":"52","author":"Liu","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551055000_67.4.590.8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13550-023-00997-0","article-title":"Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression","volume":"13","author":"Jahn","year":"2023","journal-title":"EJNMMI Res."},{"key":"2026040105551055000_67.4.590.9","unstructured":"European Agency for the Evaluation of Medicinal Products. Position paper on non-clinical safety studies to support clinical trials with a single microdose. https:\/\/iaa-ams.co.jp\/wp-content\/uploads\/2020\/10\/MD1.pdf. Published January 23, 2003. Accessed January 12, 2026."},{"key":"2026040105551055000_67.4.590.10","unstructured":"Food and Drug Administration (FDA). Guidance for industry, investigators, and reviewers: exploratory IND studies. https:\/\/www.fda.gov\/media\/72325\/download. Published January 2006. Accessed January 12, 2026."},{"key":"2026040105551055000_67.4.590.11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/cts.12390","article-title":"Microdosing and other phase 0 clinical trials: facilitating translation in drug development","volume":"9","author":"Burt","year":"2016","journal-title":"Clin Transl Sci."},{"key":"2026040105551055000_67.4.590.12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40658-019-0253-z","article-title":"Multicentre quantitative 68Ga PET\/CT performance harmonisation","volume":"6","author":"Huizing","year":"2019","journal-title":"EJNMMI Phys."},{"key":"2026040105551055000_67.4.590.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2009.11.008"},{"key":"2026040105551055000_67.4.590.14","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1007\/s00259-025-07141-1","article-title":"Improved FAPI-radiopharmaceutical pharmacokinetics from the perspectives of a dose escalation study","volume":"52","author":"Bilinska","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551055000_67.4.590.15","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00259-024-06969-3","article-title":"Effect of molar dose on the in vivo tissue biodistribution profile of FAP-targeted radioligand therapeutics","volume":"52","author":"Galbiati","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551055000_67.4.590.16","doi-asserted-by":"crossref","first-page":"132044","DOI":"10.1016\/j.ijcard.2024.132044","article-title":"Circulating soluble fibroblast activation protein (FAP) levels are independent of cardiac and extra-cardiac FAP expression determined by targeted molecular imaging in patients with myocardial FAP activation","volume":"406","author":"Tillmanns","year":"2024","journal-title":"Int J Cardiol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.271511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:17:37Z","timestamp":1785269857000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.271511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,1]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.2967\/jnumed.125.271511"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.271511","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]}}}